On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...

Daiichi Sankyo has launched a new direct-to-consumer (DTC) campaign for Enhertu — the first DTC effort for its oncology unit ...

As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...

HALIX B.V., a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of ...

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

Selection of the development candidate triggered a $3 million milestone payment to Voyager, which the Company expects to receive in the fourth quarter of 2024. Voyager is eligible to receive ...

A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's ...

We welcome Lloyd and Mene to our Board as they add significant experience and proven track records in leading R&D in the life sciences and biopharmaceutical industries,” said Caroline Dorsa, Chair of ...

The Journal sat down with Colleen Dixon, the new CEO of Spokane-based Selkirk Pharma Inc., to discusswhat the company has been up to in the last couple of years and what Dixon is focused on ...

Ionis Pharmaceuticals IONS announced that it is floating a secondary issue of 11.5 million shares of its common stock to the ...